365 related articles for article (PubMed ID: 17560271)
21. Diverse functions for DNA and RNA editing in the immune system.
Hamilton CE; Papavasiliou FN; Rosenberg BR
RNA Biol; 2010; 7(2):220-8. PubMed ID: 20220309
[TBL] [Abstract][Full Text] [Related]
22. Advantages and disadvantages of cytidine deamination.
Cascalho M
J Immunol; 2004 Jun; 172(11):6513-8. PubMed ID: 15153462
[TBL] [Abstract][Full Text] [Related]
23. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
[TBL] [Abstract][Full Text] [Related]
24. Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase.
Nabel CS; Lee JW; Wang LC; Kohli RM
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14225-30. PubMed ID: 23942124
[TBL] [Abstract][Full Text] [Related]
25. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
26. Expansions, diversification, and interindividual copy number variations of AID/APOBEC family cytidine deaminase genes in lampreys.
Holland SJ; Berghuis LM; King JJ; Iyer LM; Sikora K; Fifield H; Peter S; Quinlan EM; Sugahara F; Shingate P; Trancoso I; Iwanami N; Temereva E; Strohmeier C; Kuratani S; Venkatesh B; Evanno G; Aravind L; Schorpp M; Larijani M; Boehm T
Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3211-E3220. PubMed ID: 29555777
[TBL] [Abstract][Full Text] [Related]
27. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses.
Harris RS; Sheehy AM; Craig HM; Malim MH; Neuberger MS
Nat Immunol; 2003 Jul; 4(7):641-3. PubMed ID: 12830140
[No Abstract] [Full Text] [Related]
28. Dissociation of in vitro DNA deamination activity and physiological functions of AID mutants.
Shivarov V; Shinkura R; Honjo T
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15866-71. PubMed ID: 18832469
[TBL] [Abstract][Full Text] [Related]
29. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
Severi F; Chicca A; Conticello SG
Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
[TBL] [Abstract][Full Text] [Related]
30. An overview of cytidine deaminases.
Navaratnam N; Sarwar R
Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
[TBL] [Abstract][Full Text] [Related]
31. Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase.
Anant S; Yu H; Davidson NO
Biol Chem; 1998; 379(8-9):1075-81. PubMed ID: 9792440
[TBL] [Abstract][Full Text] [Related]
32. APOBEC-mediated editing of viral RNA.
Bishop KN; Holmes RK; Sheehy AM; Malim MH
Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
[TBL] [Abstract][Full Text] [Related]
33. AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates.
Liu MC; Liao WY; Buckley KM; Yang SY; Rast JP; Fugmann SD
Nat Commun; 2018 May; 9(1):1948. PubMed ID: 29769532
[TBL] [Abstract][Full Text] [Related]
34. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
Lindley RA; Hall NE
Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
[TBL] [Abstract][Full Text] [Related]
35. Zinc-binding domain-dependent, deaminase-independent actions of apolipoprotein B mRNA-editing enzyme, catalytic polypeptide 2 (Apobec2), mediate its effect on zebrafish retina regeneration.
Powell C; Cornblath E; Goldman D
J Biol Chem; 2014 Oct; 289(42):28924-41. PubMed ID: 25190811
[TBL] [Abstract][Full Text] [Related]
36. APOBECs and virus restriction.
Harris RS; Dudley JP
Virology; 2015 May; 479-480():131-45. PubMed ID: 25818029
[TBL] [Abstract][Full Text] [Related]
37. Biochemical basis of immunological and retroviral responses to DNA-targeted cytosine deamination by activation-induced cytidine deaminase and APOBEC3G.
Chelico L; Pham P; Petruska J; Goodman MF
J Biol Chem; 2009 Oct; 284(41):27761-27765. PubMed ID: 19684020
[TBL] [Abstract][Full Text] [Related]
38. [Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis].
Shilova ON; Tsyba DL; Shilov ES
Mol Biol (Mosk); 2022; 56(1):55-68. PubMed ID: 35082258
[TBL] [Abstract][Full Text] [Related]
39. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
[TBL] [Abstract][Full Text] [Related]
40. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
